ecrin-mdr-crcClinical2008colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2639470Japan11ECRIN MDRCompletedfalseA randomized controlled, open-labelled early phase II trial comparing incidence of FOLFIRI.3-induced diarrhea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancerInterventions: Hangeshashinto(TJ-14) Oral alkalization Primary outcome(s): the incidence of all grade of a late-onset diarrhea during the treatment period Study Design: Parallel Randomized2008-11-152639470JPRN-UMIN000024219